GO:0070372 regulation of ERK1 and ERK2 cascade: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070372 describes any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
• ERK1 and ERK2 (also known as MAPK3 and MAPK1) are structurally related serine/threonine kinases that serve as terminal effectors of the classical RAS-RAF-MEK-ERK signaling module.
• Regulation of this cascade occurs at multiple levels, including scaffold proteins, phosphatases, and feedback phosphorylation of upstream components.
• Dysregulated ERK1/2 signaling is a hallmark of many cancers, where it drives proliferation, survival, and metastasis.
• The ERK1/2 cascade also controls normal developmental processes such as astrocyte proliferation and differentiation.
• Small-molecule inhibitors targeting ERK1/2 or their upstream activators are under active preclinical and clinical investigation.
Description
The ERK1 and ERK2 cascade is one of the most extensively studied mitogen-activated protein kinase (MAPK) signaling pathways, transducing extracellular cues into diverse cellular responses including proliferation, differentiation, and survival. The Gene Ontology term GO:0070372, regulation of ERK1 and ERK2 cascade, encompasses any process that modulates the frequency, rate or extent of signal transduction mediated by this cascade. This regulatory control is essential for normal physiology, and its perturbation contributes to diseases such as cancer and developmental disorders. Understanding how the ERK1/2 cascade is regulated at the molecular level is therefore a central goal in cell signaling research. Researchers study this process using a wide array of biochemical, genetic, and pharmacological tools, including small-molecule inhibitors and CRISPR-based gene editing.
regulation of ERK1 and ERK2 cascade At A Glance
| GO ID | GO:0070372 |
|---|---|
| GO term | regulation of ERK1 and ERK2 cascade |
| Ontology | biological_process |
| Synonym | regulation of ERK1/2 cascade; regulation of ERK1 and ERK2 signaling pathway; regulation of MAPK1 cascade; regulation of MAPK3 cascade |
| Major function | Modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade |
| Related kinases | ERK1 (MAPK3), ERK2 (MAPK1), MEK1/2, RAF, RAS |
| Cellular context | Cytoplasm, nucleus, and scaffold-associated signaling complexes |
| Disease relevance | Cancer, developmental disorders, inflammatory diseases |
What Is GO:0070372?
GO:0070372, regulation of ERK1 and ERK2 cascade, is defined as any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. In other words, it includes all molecular events that tune the strength, duration, or spatial localization of ERK1/2 signaling, from receptor activation to downstream substrate phosphorylation.
Why Is regulation of ERK1 and ERK2 cascade Important in Cell Biology?
The ERK1/2 cascade is a central node in signal transduction, and its dysregulation is implicated in a broad spectrum of human diseases, particularly cancer. Because GO:0070372 covers all regulatory inputs that shape ERK1/2 signaling output, it provides a framework for understanding how cells integrate diverse signals to make fate decisions. Moreover, pharmacological targeting of this cascade is a major therapeutic strategy, making its regulation a key area of translational research.
• Controls fundamental cellular processes including proliferation, differentiation, and survival.
• Dysregulation is frequently observed in human tumors, contributing to oncogenesis.
• Plays a critical role in brain development, including astrocyte proliferation and differentiation.
• Regulates apoptosis and chemoresistance in leukemic cells through Bcl2 phosphorylation.
• Is a target for small-molecule inhibitors with potential anticancer activity.
• Modulates immune cell functions and tumor invasion in thyroid cancer.
• Feedback regulation by phosphatases and scaffold proteins fine-tunes signal duration and intensity.
• Cross-talk with other signaling pathways influences cellular outcomes.
What Happens During regulation of ERK1 and ERK2 cascade?
Activation of the core kinase module
In simple terms: A chain of kinases turns each other on, ultimately activating ERK1/2.
The ERK1/2 cascade is typically initiated by growth factor receptors that activate RAS, which in turn recruits and activates RAF kinases. RAF phosphorylates and activates MEK1/2, which then phosphorylate ERK1 and ERK2 on threonine and tyrosine residues within their activation loop. This sequential phosphorylation cascade amplifies the signal and allows for tight regulation.
Scaffold proteins and spatial regulation
In simple terms: Scaffold proteins hold the kinases together to ensure efficient and specific signaling.
Scaffold proteins such as KSR and MP1 bind multiple components of the ERK1/2 cascade, coordinating their activation and localizing the signal to specific subcellular compartments. This spatial organization is crucial for determining the specificity and duration of ERK1/2 signaling.
Feedback phosphorylation and phosphatases
In simple terms: The pathway can shut itself off by modifying upstream components or removing phosphate groups.
Activated ERK1/2 can phosphorylate upstream regulators such as SOS and RAF, providing negative feedback that attenuates signaling. Additionally, dual-specificity phosphatases (DUSPs) dephosphorylate ERK1/2, terminating the signal and contributing to the dynamic regulation of the cascade.
Subcellular trafficking and substrate phosphorylation
In simple terms: Once active, ERK1/2 move into the nucleus and other compartments to phosphorylate many targets.
Activated ERK1/2 translocate to the nucleus and other cellular compartments where they phosphorylate a wide range of substrates, including transcription factors and cytoskeletal proteins. This substrate diversity underlies the pleiotropic effects of ERK1/2 signaling on cell behavior.
Key Genes Involved in GO:0070372 regulation of ERK1 and ERK2 cascade
The following genes and proteins are key components or regulators of the ERK1 and ERK2 cascade.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPK3 (ERK1) | Terminal kinase of the cascade | Central effector; knockout models show impaired proliferation |
| MAPK1 (ERK2) | Terminal kinase of the cascade | Essential for development; knockout is embryonic lethal |
| MAP2K1 (MEK1) | Phosphorylates ERK1/2 | Target for inhibitors; mutations in cancers |
| MAP2K2 (MEK2) | Phosphorylates ERK1/2 | Redundant with MEK1; drug target |
| RAF1 | Activates MEK1/2 | Oncogene; feedback regulation by ERK |
| BRAF | Activates MEK1/2 | Frequently mutated in melanoma; drug target |
| HRAS | Activates RAF | Oncogene; upstream regulator |
| KRAS | Activates RAF | Oncogene; prevalent in pancreatic and lung cancers |
| NRAS | Activates RAF | Oncogene; mutated in melanoma |
| SOS1 | GEF for RAS | Feedback phosphorylation by ERK |
| DUSP1 | Phosphatase for ERK1/2 | Negative regulator; controls signal duration |
| DUSP6 | Phosphatase for ERK1/2 | Feedback regulator; specificity for ERK |
| KSR1 | Scaffold protein | Coordinates RAF-MEK-ERK module |
| MP1 (LAMTOR3) | Scaffold protein | Enhances MEK-ERK interaction |
| Bcl2 | Anti-apoptotic protein | Phosphorylated by ERK; linked to chemoresistance |
| TIM3 (HAVCR2) | Immune checkpoint | Activates ERK1/2 in thyroid tumors |
| GFAP | Astrocyte marker | ERK1/2 regulates astrocyte proliferation |
How Is regulation of ERK1 and ERK2 cascade Regulated?
The ERK1/2 cascade is subject to multiple layers of regulation. Negative feedback loops involving ERK-mediated phosphorylation of SOS and RAF dampen signal intensity. Dual-specificity phosphatases (DUSPs) dephosphorylate ERK1/2, providing an off-switch. Scaffold proteins such as KSR and MP1 modulate the efficiency and specificity of the cascade. Additionally, cross-talk with other signaling pathways, such as the PI3K-AKT pathway, can influence ERK1/2 activity.
regulation of ERK1 and ERK2 cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRAF | Melanoma, colorectal cancer | Knock-in of V600E mutation in cell lines |
| KRAS | Pancreatic, lung, colorectal cancer | Knockout or point mutation in cancer cell lines |
| MAP2K1 | Cardiofaciocutaneous syndrome | Knock-in of activating mutations |
| DUSP6 | Cancer, developmental disorders | Overexpression or knockout in cell models |
| TIM3 (HAVCR2) | Thyroid cancer invasion | Knockout in thyroid cancer cell lines |
ERK1/2 cascade in cancer
Constitutive activation of the ERK1/2 cascade due to mutations in RAS or RAF is a common feature of many cancers, driving uncontrolled proliferation and survival. Targeting this pathway with small-molecule inhibitors has shown promise in preclinical and clinical studies.
ERK1/2 in developmental disorders
Germline mutations in components of the ERK1/2 cascade cause developmental syndromes collectively known as RASopathies, which include cardiac defects and cognitive impairments. Proper regulation of ERK1/2 is essential for normal development.
ERK1/2 in immune regulation and thyroid cancer
TIM3, an immune checkpoint protein, activates the ERK1/2 pathway to promote invasion and migration of thyroid tumor cells. This highlights the role of ERK1/2 in tumor microenvironment interactions.
ERK1/2 in leukemic chemoresistance
ERK1/2-mediated phosphorylation of Bcl2 contributes to chemoresistance in leukemic cells, suggesting that targeting this regulatory node could improve therapy.
From regulation of ERK1 and ERK2 cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ERK1 affect proliferation? | MAPK3 knockout cell line |
| Does a specific mutation in MEK1 activate the pathway? | Point mutation knock-in of MAP2K1 |
| How does ERK2 localize in live cells? | Tagged knock-in of MAPK1 with fluorescent protein |
| Does overexpression of DUSP6 reduce ERK signaling? | DUSP6 overexpression cell line |
| What genes are essential for ERK1/2 cascade regulation? | CRISPR library screening |
| How does TIM3 regulate ERK1/2 in thyroid cancer? | TIM3 knockout in thyroid cancer cells |
How to Study the regulation of ERK1 and ERK2 cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Phospho-ERK1/2 levels | Assessing pathway activation |
| Kinase assay | ERK1/2 catalytic activity | Evaluating inhibitors |
| Live-cell imaging | ERK1/2 subcellular localization | Studying signaling dynamics |
| RNA-seq | Transcriptional changes | Identifying downstream targets |
| CRISPR screen | Gene essentiality for ERK signaling | Discovering regulators |
| Proteomics | Protein interactions and phosphorylation | Mapping signaling networks |
| Immunohistochemistry | Phospho-ERK in tissues | Clinical correlation studies |
Western blotting and phospho-specific antibodies
Western blotting with antibodies against phosphorylated ERK1/2 (Thr202/Tyr204) is a standard method to assess activation status of the cascade.
Kinase activity assays
In vitro kinase assays using recombinant ERK1/2 and substrate peptides measure catalytic activity and are used to evaluate inhibitors.
Live-cell imaging of ERK dynamics
Fluorescently tagged ERK1/2 expressed in cells allows real-time monitoring of nuclear translocation and signaling dynamics.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of the ERK1/2 cascade.
How CRISPR Can Be Used to Study GO:0070372 regulation of ERK1 and ERK2 cascade
Knockout
CRISPR knockout of MAPK1 or MAPK3 can reveal their specific roles in ERK1/2 cascade regulation and cellular phenotypes.
Point Mutation
Introducing point mutations such as BRAF V600E or MEK1 activating mutations via CRISPR allows study of constitutive ERK1/2 activation in isogenic backgrounds.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous MAPK1/3 loci enables real-time imaging and biochemical analysis of ERK1/2.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate levels of regulators like DUSP6 to study their impact on ERK1/2 signaling.
How EDITGENE Supports regulation of ERK1 and ERK2 cascade Research
Researchers studying regulation of ERK1 and ERK2 cascade-related genes often need to determine whether a candidate gene is causally involved in pathway regulation or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of ERK1 and ERK2 cascade research.
Frequently Asked Questions About regulation of ERK1 and ERK2 cascade
What is GO:0070372?
GO:0070372 is the Gene Ontology term for regulation of ERK1 and ERK2 cascade, defined as any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
What genes are involved in regulation of ERK1 and ERK2 cascade?
Key genes include MAPK3 (ERK1), MAPK1 (ERK2), MAP2K1 (MEK1), MAP2K2 (MEK2), RAF1, BRAF, HRAS, KRAS, NRAS, DUSP1, DUSP6, KSR1, and others.
How is the ERK1/2 cascade regulated?
It is regulated by phosphorylation cascades, scaffold proteins, feedback phosphorylation, and phosphatases such as DUSPs.
What diseases are associated with dysregulated ERK1/2 signaling?
Cancer, developmental disorders (RASopathies), and immune-related conditions.
What methods are used to study ERK1/2 cascade regulation?
Western blotting, kinase assays, live-cell imaging, CRISPR screens, and proteomics.
Can CRISPR be used to study ERK1/2 cascade?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect the pathway.
What are the synonyms for GO:0070372?
Synonyms include regulation of ERK1/2 cascade, regulation of ERK1 and ERK2 signaling pathway, regulation of MAPK1 cascade, and regulation of MAPK3 cascade.
Why is ERK1/2 signaling important in cancer?
Constitutive activation drives proliferation and survival; mutations in RAS/RAF are common in cancers.
What is the role of DUSP6 in ERK1/2 regulation?
DUSP6 is a phosphatase that dephosphorylates ERK1/2, acting as a negative regulator.
How does TIM3 affect ERK1/2 in thyroid cancer?
TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumor cells.
Conclusion
GO:0070372, regulation of ERK1 and ERK2 cascade, is a fundamental biological process that controls diverse cellular outcomes. Its dysregulation is linked to cancer and developmental disorders, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and small-molecule inhibitors continue to shed light on the complex regulation of this pathway.
References
- 1. Guo YJ et al.. 2020. ERK/MAPK signalling pathway and tumorigenesis.. Exp Ther Med 19(3):1997-2007 PMID: 32104259
- 2. Roskoski R Jr. 2012. ERK1/2 MAP kinases: structure, function, and regulation.. Pharmacol Res 66(2):105-43 PMID: 22569528
- 3. Robbins DJ et al.. 1993. Regulation and properties of extracellular signal-regulated protein kinases 1, 2, and 3.. J Am Soc Nephrol 4(5):1104-10 PMID: 8305637
- 4. Sah VK et al.. 2025. Advances in ERK1/2 inhibition: a medicinal chemistry perspective on structure and regulation.. J Enzyme Inhib Med Chem 40(1):2555510 PMID: 40928301
- 5. Sammons RM et al.. 2023. Identification and biochemical characterization of small molecule inhibitors of ERK2 that target the D-recruitment site.. Methods Enzymol 690:445-499 PMID: 37858538
- 6. Deng X et al.. 2001. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.. J Natl Cancer Inst Monogr PMID: 11158204
- 7. Cheng P et al.. 2013. The role of ERK1/2 in the regulation of proliferation and differentiation of astrocytes in developing brain.. Int J Dev Neurosci 31(8):783-9 PMID: 24113259
- 8. Jin X et al.. 2024. TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors.. PLoS One 19(4):e0297695 PMID: 38568917
